Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Strain

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Annals of Internal Medicine|July 1, 1993
Dose-response effects of methadone in the treatment of opioid dependenceE C Strain, M L Stitzer, I A Liebson, et al.
Clinical Pharmacology and Therapeutics|August 1, 1996
Opioid antagonist effects of dezocine in opioid-dependent humansE C Strain, K L Preston, I A Liebson, et al.
NIDA Research Monograph|January 1, 1991
Effects of cocaine alone and in combination with bromocriptine in human cocaine abusersK L Preston, J T Sullivan, E C Strain, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteersE C Strain, K L Preston, I A Liebson, et al.
Psychopharmacology|May 16, 2001
Effects of buprenorphine/naloxone in opioid-dependent humansK B Stoller, G E Bigelow, S L Walsh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humansS L Walsh, B Geter-Douglas, E C Strain, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadoneE C Strain, K L Preston, I A Liebson, et al.
Psychopharmacology|October 3, 2007
Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockadeS L Walsh, A E Chausmer, E C Strain, et al.
NIDA Research Monograph|January 1, 1991
Intravenous drug abusers with antisocial personality disorder: high rate of HIV-1 infectionR K Brooner, G E Bigelow, L Greenfield, et al.
The American Journal on Addictions|July 11, 2001
Gradual dose taper following chronic buprenorphineA B Becker, E C Strain, G E Bigelow, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Annals of Internal Medicine|July 1, 1993
Dose-response effects of methadone in the treatment of opioid dependenceE C Strain, M L Stitzer, I A Liebson, et al.
Clinical Pharmacology and Therapeutics|August 1, 1996
Opioid antagonist effects of dezocine in opioid-dependent humansE C Strain, K L Preston, I A Liebson, et al.
NIDA Research Monograph|January 1, 1991
Effects of cocaine alone and in combination with bromocriptine in human cocaine abusersK L Preston, J T Sullivan, E C Strain, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteersE C Strain, K L Preston, I A Liebson, et al.
Psychopharmacology|May 16, 2001
Effects of buprenorphine/naloxone in opioid-dependent humansK B Stoller, G E Bigelow, S L Walsh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humansS L Walsh, B Geter-Douglas, E C Strain, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadoneE C Strain, K L Preston, I A Liebson, et al.
Psychopharmacology|October 3, 2007
Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockadeS L Walsh, A E Chausmer, E C Strain, et al.
NIDA Research Monograph|January 1, 1991
Intravenous drug abusers with antisocial personality disorder: high rate of HIV-1 infectionR K Brooner, G E Bigelow, L Greenfield, et al.
The American Journal on Addictions|July 11, 2001
Gradual dose taper following chronic buprenorphineA B Becker, E C Strain, G E Bigelow, et al.
Pageof 5